KYMR – kymera therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Does Positive KT-621 Atopic Dermatitis Data Change The Bull Case For Kymera Therapeutics (KYMR)? [Yahoo! Finance]
Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting [Yahoo! Finance]
Kymera Therapeutics Presents KT-621 BroADen Data in Late-Breaking Research Session at the American Academy of Dermatology (AAD) Annual Meeting
Kymera Therapeutics (KYMR) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating on the stock.
Kymera Trials IRF5 And STAT6 Degraders As Market Weighs Long Term Upside [Yahoo! Finance]
Form 4 Kymera Therapeutics, For: Mar 31 Filed by: Chadwick Jeremy G
Form 4 Kymera Therapeutics, For: Mar 31 Filed by: Ridloff Elena
Form 144 Kymera Therapeutics, Filed by: Ridloff Elena
Form 144 Kymera Therapeutics, Filed by: Chadwick Jeremy G
Form 144 Kymera Therapeutics, Filed by: Chadwick Jeremy G
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.